Abstract
We describe the outcomes of 16 cases of imported loiasis in Italy. Patients had microfilaremia <20,000/mL and were treated with high-dose albendazole for 28 days and a single dose of ivermectin. This combination might be an effective treatment option in nonendemic areas, when diethylcarbamazine, the drug of choice, is not available.
| Original language | English |
|---|---|
| Pages (from-to) | 1574-1576 |
| Number of pages | 3 |
| Journal | Emerging Infectious Diseases |
| Volume | 25 |
| Issue number | 8 |
| DOIs | |
| Publication status | Published - Aug 2019 |
Fingerprint
ASJC Scopus subject areas
- Epidemiology
- Microbiology (medical)
- Infectious Diseases
Cite this
Efficacy of high-dose albendazole with ivermectin for treating imported Loiasis, Italy. / Gobbi, Federico; Buonfrate, Dora; Tamarozzi, Francesca; Degani, Monica; Angheben, Andrea; Bisoffi, Zeno.
In: Emerging Infectious Diseases, Vol. 25, No. 8, 08.2019, p. 1574-1576.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Efficacy of high-dose albendazole with ivermectin for treating imported Loiasis, Italy
AU - Gobbi, Federico
AU - Buonfrate, Dora
AU - Tamarozzi, Francesca
AU - Degani, Monica
AU - Angheben, Andrea
AU - Bisoffi, Zeno
PY - 2019/8
Y1 - 2019/8
N2 - We describe the outcomes of 16 cases of imported loiasis in Italy. Patients had microfilaremia <20,000/mL and were treated with high-dose albendazole for 28 days and a single dose of ivermectin. This combination might be an effective treatment option in nonendemic areas, when diethylcarbamazine, the drug of choice, is not available.
AB - We describe the outcomes of 16 cases of imported loiasis in Italy. Patients had microfilaremia <20,000/mL and were treated with high-dose albendazole for 28 days and a single dose of ivermectin. This combination might be an effective treatment option in nonendemic areas, when diethylcarbamazine, the drug of choice, is not available.
UR - http://www.scopus.com/inward/record.url?scp=85069919209&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85069919209&partnerID=8YFLogxK
U2 - 10.3201/eid2508.190011
DO - 10.3201/eid2508.190011
M3 - Article
C2 - 31310225
AN - SCOPUS:85069919209
VL - 25
SP - 1574
EP - 1576
JO - Emerging Infectious Diseases
JF - Emerging Infectious Diseases
SN - 1080-6040
IS - 8
ER -